UniProt ID | UBP28_HUMAN | |
---|---|---|
UniProt AC | Q96RU2 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase 28 | |
Gene Name | USP28 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1077 | |
Subcellular Localization | Nucleus, nucleoplasm . | |
Protein Description | Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) in a subset of colorectal cancers (CRC) cells. [PubMed: 24623306] | |
Protein Sequence | MTAELQQDDAAGAADGHGSSCQMLLNQLREITGIQDPSFLHEALKASNGDITQAVSLLTDERVKEPSQDTVATEPSEVEGSAANKEVLAKVIDLTHDNKDDLQAAIALSLLESPKIQADGRDLNRMHEATSAETKRSKRKRCEVWGENPNPNDWRRVDGWPVGLKNVGNTCWFSAVIQSLFQLPEFRRLVLSYSLPQNVLENCRSHTEKRNIMFMQELQYLFALMMGSNRKFVDPSAALDLLKGAFRSSEEQQQDVSEFTHKLLDWLEDAFQLAVNVNSPRNKSENPMVQLFYGTFLTEGVREGKPFCNNETFGQYPLQVNGYRNLDECLEGAMVEGDVELLPSDHSVKYGQERWFTKLPPVLTFELSRFEFNQSLGQPEKIHNKLEFPQIIYMDRYMYRSKELIRNKRECIRKLKEEIKILQQKLERYVKYGSGPARFPLPDMLKYVIEFASTKPASESCPPESDTHMTLPLSSVHCSVSDQTSKESTSTESSSQDVESTFSSPEDSLPKSKPLTSSRSSMEMPSQPAPRTVTDEEINFVKTCLQRWRSEIEQDIQDLKTCIASTTQTIEQMYCDPLLRQVPYRLHAVLVHEGQANAGHYWAYIYNQPRQSWLKYNDISVTESSWEEVERDSYGGLRNVSAYCLMYINDKLPYFNAEAAPTESDQMSEVEALSVELKHYIQEDNWRFEQEVEEWEEEQSCKIPQMESSTNSSSQDYSTSQEPSVASSHGVRCLSSEHAVIVKEQTAQAIANTARAYEKSGVEAALSEVMLSPAMQGVILAIAKARQTFDRDGSEAGLIKAFHEEYSRLYQLAKETPTSHSDPRLQHVLVYFFQNEAPKRVVERTLLEQFADKNLSYDERSISIMKVAQAKLKEIGPDDMNMEEYKKWHEDYSLFRKVSVYLLTGLELYQKGKYQEALSYLVYAYQSNAALLMKGPRRGVKESVIALYRRKCLLELNAKAASLFETNDDHSVTEGINVMNELIIPCIHLIINNDISKDDLDAIEVMRNHWCSYLGQDIAENLQLCLGEFLPRLLDPSAEIIVLKEPPTIRPNSPYDLCSRFAAVMESIQGVSTVTVK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
38 | Phosphorylation | ITGIQDPSFLHEALK HHCCCCHHHHHHHHH | 49.05 | 28555341 | |
45 | Ubiquitination | SFLHEALKASNGDIT HHHHHHHHHCCCCHH | 57.74 | - | |
64 | Ubiquitination | LLTDERVKEPSQDTV HHCCCCCCCCCCCCC | 70.86 | 21906983 | |
64 (in isoform 1) | Ubiquitination | - | 70.86 | 21890473 | |
64 (in isoform 2) | Ubiquitination | - | 70.86 | 21890473 | |
67 | Phosphorylation | DERVKEPSQDTVATE CCCCCCCCCCCCCCC | 41.60 | 17525332 | |
70 | Phosphorylation | VKEPSQDTVATEPSE CCCCCCCCCCCCHHH | 12.38 | 25159151 | |
73 | Phosphorylation | PSQDTVATEPSEVEG CCCCCCCCCHHHCCC | 44.06 | 27732954 | |
85 | Ubiquitination | VEGSAANKEVLAKVI CCCCHHCHHHHHHHH | 44.46 | - | |
90 | Ubiquitination | ANKEVLAKVIDLTHD HCHHHHHHHHHCCCC | 35.25 | - | |
95 | Phosphorylation | LAKVIDLTHDNKDDL HHHHHHCCCCCHHHH | 24.36 | 28674419 | |
99 | Sumoylation | IDLTHDNKDDLQAAI HHCCCCCHHHHHHHH | 59.69 | 28112733 | |
99 | Sumoylation | IDLTHDNKDDLQAAI HHCCCCCHHHHHHHH | 59.69 | - | |
109 | Phosphorylation | LQAAIALSLLESPKI HHHHHHHHHHHCCCC | 23.14 | 27080861 | |
113 | Phosphorylation | IALSLLESPKIQADG HHHHHHHCCCCCCCC | 31.31 | 29496963 | |
130 | Phosphorylation | LNRMHEATSAETKRS HHHHHHHCCHHHHHH | 26.03 | 25159151 | |
131 | Phosphorylation | NRMHEATSAETKRSK HHHHHHCCHHHHHHH | 31.02 | 20068231 | |
134 | Phosphorylation | HEATSAETKRSKRKR HHHCCHHHHHHHHHC | 31.32 | 29396449 | |
220 | Phosphorylation | MFMQELQYLFALMMG HHHHHHHHHHHHHHC | 19.19 | 24043423 | |
228 | Phosphorylation | LFALMMGSNRKFVDP HHHHHHCCCCCCCCH | 18.63 | 24043423 | |
243 (in isoform 2) | Ubiquitination | - | 56.33 | 21890473 | |
243 (in isoform 1) | Ubiquitination | - | 56.33 | 21890473 | |
243 | Ubiquitination | SAALDLLKGAFRSSE HHHHHHHHHHHCCCH | 56.33 | 21890473 | |
243 | Ubiquitination | SAALDLLKGAFRSSE HHHHHHHHHHHCCCH | 56.33 | 21890473 | |
248 | Phosphorylation | LLKGAFRSSEEQQQD HHHHHHCCCHHHHHC | 35.33 | 29214152 | |
249 | Phosphorylation | LKGAFRSSEEQQQDV HHHHHCCCHHHHHCH | 40.68 | 29214152 | |
279 | Phosphorylation | QLAVNVNSPRNKSEN HHHHHCCCCCCCCCC | 22.43 | 27422710 | |
375 | Phosphorylation | SRFEFNQSLGQPEKI EEHHCCHHCCCCHHH | 35.26 | 25159151 | |
381 | Ubiquitination | QSLGQPEKIHNKLEF HHCCCCHHHHCCCCC | 56.82 | - | |
420 | Ubiquitination | RKLKEEIKILQQKLE HHHHHHHHHHHHHHH | 40.41 | - | |
425 | Ubiquitination | EIKILQQKLERYVKY HHHHHHHHHHHHHHH | 39.08 | - | |
431 | Ubiquitination | QKLERYVKYGSGPAR HHHHHHHHHCCCCCC | 34.65 | - | |
447 | Phosphorylation | PLPDMLKYVIEFAST CCCHHHHHHHHHHCC | 11.60 | - | |
488 | Phosphorylation | SDQTSKESTSTESSS CCCCCCCCCCCCCCC | 31.24 | 20873877 | |
489 | Phosphorylation | DQTSKESTSTESSSQ CCCCCCCCCCCCCCC | 40.54 | 20873877 | |
490 | Phosphorylation | QTSKESTSTESSSQD CCCCCCCCCCCCCCC | 39.18 | 20873877 | |
491 | Phosphorylation | TSKESTSTESSSQDV CCCCCCCCCCCCCCH | 39.72 | 20873877 | |
493 | Phosphorylation | KESTSTESSSQDVES CCCCCCCCCCCCHHH | 35.06 | 25159151 | |
494 | Phosphorylation | ESTSTESSSQDVEST CCCCCCCCCCCHHHH | 26.28 | 20873877 | |
495 | Phosphorylation | STSTESSSQDVESTF CCCCCCCCCCHHHHC | 39.41 | 17478428 | |
500 | Phosphorylation | SSSQDVESTFSSPED CCCCCHHHHCCCCCC | 34.30 | 20873877 | |
501 | Phosphorylation | SSQDVESTFSSPEDS CCCCHHHHCCCCCCC | 17.65 | 20873877 | |
503 | Phosphorylation | QDVESTFSSPEDSLP CCHHHHCCCCCCCCC | 45.10 | 25159151 | |
504 | Phosphorylation | DVESTFSSPEDSLPK CHHHHCCCCCCCCCC | 28.28 | 28985074 | |
508 | Phosphorylation | TFSSPEDSLPKSKPL HCCCCCCCCCCCCCC | 44.93 | 27251275 | |
512 | Phosphorylation | PEDSLPKSKPLTSSR CCCCCCCCCCCCCCC | 37.25 | 24719451 | |
513 | Ubiquitination | EDSLPKSKPLTSSRS CCCCCCCCCCCCCCC | 50.61 | - | |
516 | Phosphorylation | LPKSKPLTSSRSSME CCCCCCCCCCCCCCC | 32.93 | 26330541 | |
517 | Phosphorylation | PKSKPLTSSRSSMEM CCCCCCCCCCCCCCC | 31.28 | 25159151 | |
518 | Phosphorylation | KSKPLTSSRSSMEMP CCCCCCCCCCCCCCC | 30.83 | 25627689 | |
520 | Phosphorylation | KPLTSSRSSMEMPSQ CCCCCCCCCCCCCCC | 35.66 | 25159151 | |
521 | Phosphorylation | PLTSSRSSMEMPSQP CCCCCCCCCCCCCCC | 20.04 | 25159151 | |
542 | Ubiquitination | DEEINFVKTCLQRWR HHHHHHHHHHHHHHH | 29.41 | - | |
543 | Phosphorylation | EEINFVKTCLQRWRS HHHHHHHHHHHHHHH | 17.10 | - | |
550 | Phosphorylation | TCLQRWRSEIEQDIQ HHHHHHHHHHHHHHH | 35.65 | 25159151 | |
654 | Phosphorylation | YINDKLPYFNAEAAP HHCCCCCCCCCCCCC | 21.65 | - | |
708 | Phosphorylation | CKIPQMESSTNSSSQ CCCCCCCCCCCCCCC | 36.80 | 24043423 | |
709 | Phosphorylation | KIPQMESSTNSSSQD CCCCCCCCCCCCCCC | 20.50 | 24043423 | |
710 | Phosphorylation | IPQMESSTNSSSQDY CCCCCCCCCCCCCCC | 48.69 | 28348404 | |
712 | Phosphorylation | QMESSTNSSSQDYST CCCCCCCCCCCCCCC | 31.30 | 29116813 | |
713 | Phosphorylation | MESSTNSSSQDYSTS CCCCCCCCCCCCCCC | 33.80 | 29116813 | |
714 | Phosphorylation | ESSTNSSSQDYSTSQ CCCCCCCCCCCCCCC | 27.22 | 17525332 | |
717 | Phosphorylation | TNSSSQDYSTSQEPS CCCCCCCCCCCCCCC | 13.25 | 24043423 | |
718 | Phosphorylation | NSSSQDYSTSQEPSV CCCCCCCCCCCCCCH | 29.85 | 23312004 | |
719 | Phosphorylation | SSSQDYSTSQEPSVA CCCCCCCCCCCCCHH | 28.35 | 23312004 | |
720 | Phosphorylation | SSQDYSTSQEPSVAS CCCCCCCCCCCCHHH | 26.97 | 17478428 | |
735 | Phosphorylation | SHGVRCLSSEHAVIV HCCCEECCCCCEEEE | 36.99 | 24719451 | |
736 | Phosphorylation | HGVRCLSSEHAVIVK CCCEECCCCCEEEEE | 22.06 | 28348404 | |
753 | Phosphorylation | TAQAIANTARAYEKS HHHHHHHHHHHHHHH | 14.43 | 21712546 | |
788 | Phosphorylation | AIAKARQTFDRDGSE HHHHHHHHCCCCCCH | 23.19 | 23312004 | |
794 | Phosphorylation | QTFDRDGSEAGLIKA HHCCCCCCHHHHHHH | 28.67 | 29970186 | |
807 (in isoform 2) | Ubiquitination | - | 21.06 | 21890473 | |
839 | Ubiquitination | FFQNEAPKRVVERTL HHCCCCCHHHHHHHH | 65.94 | 2190698 | |
839 (in isoform 1) | Ubiquitination | - | 65.94 | 21890473 | |
853 | Ubiquitination | LLEQFADKNLSYDER HHHHHHCCCCCCCHH | 57.25 | - | |
856 | Phosphorylation | QFADKNLSYDERSIS HHHCCCCCCCHHHHH | 39.67 | 22210691 | |
857 | Phosphorylation | FADKNLSYDERSISI HHCCCCCCCHHHHHH | 25.62 | 22210691 | |
861 | Phosphorylation | NLSYDERSISIMKVA CCCCCHHHHHHHHHH | 20.74 | 22210691 | |
897 | Ubiquitination | EDYSLFRKVSVYLLT HHHHHHHHHHHHHHH | 31.37 | - | |
901 | Phosphorylation | LFRKVSVYLLTGLEL HHHHHHHHHHHCHHH | 6.62 | 21955146 | |
914 | Phosphorylation | ELYQKGKYQEALSYL HHHHCCCHHHHHHHH | 21.91 | 29978859 | |
919 | Phosphorylation | GKYQEALSYLVYAYQ CCHHHHHHHHHHHHH | 24.38 | 29978859 | |
920 | Phosphorylation | KYQEALSYLVYAYQS CHHHHHHHHHHHHHC | 10.88 | 22210691 | |
923 | Phosphorylation | EALSYLVYAYQSNAA HHHHHHHHHHHCCHH | 9.30 | 29978859 | |
925 | Phosphorylation | LSYLVYAYQSNAALL HHHHHHHHHCCHHHH | 8.52 | 29978859 | |
927 | Phosphorylation | YLVYAYQSNAALLMK HHHHHHHCCHHHHCC | 18.76 | 29978859 | |
943 | Phosphorylation | PRRGVKESVIALYRR CCCCHHHHHHHHHHH | 17.07 | 23403867 | |
948 | Phosphorylation | KESVIALYRRKCLLE HHHHHHHHHHHHHHH | 10.19 | 23403867 | |
1037 | Phosphorylation | LPRLLDPSAEIIVLK HHHHHCCCCEEEEEC | 37.89 | 27080861 | |
1048 | Phosphorylation | IVLKEPPTIRPNSPY EEECCCCCCCCCCHH | 40.09 | 24623306 | |
1053 | Phosphorylation | PPTIRPNSPYDLCSR CCCCCCCCHHHHHHH | 27.76 | 23401153 | |
1055 | Phosphorylation | TIRPNSPYDLCSRFA CCCCCCHHHHHHHHH | 22.74 | 22617229 | |
1059 | Phosphorylation | NSPYDLCSRFAAVME CCHHHHHHHHHHHHH | 37.42 | 28450419 | |
1067 | Phosphorylation | RFAAVMESIQGVSTV HHHHHHHHCCCCEEE | 11.34 | 20860994 | |
1075 | Phosphorylation | IQGVSTVTVK----- CCCCEEEEEC----- | 23.75 | 20860994 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP28_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response."; Zhang D., Zaugg K., Mak T.W., Elledge S.J.; Cell 126:529-542(2006). Cited for: FUNCTION, INTERACTION WITH TP53BP1, PHOSPHORYLATION AT SER-67 ANDSER-714, AND MUTAGENESIS OF CYS-171. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67 AND SER-714, AND MASSSPECTROMETRY. |